Anzeige
Mehr »
Login
Mittwoch, 29.05.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Künstliche Intelligenz lässt die Nachfrage explodieren - so profitieren Anleger
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PH5Q | ISIN: KYG9390W1015 | Ticker-Symbol: VB0
Stuttgart
29.05.24
10:33 Uhr
0,073 Euro
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
VIVA BIOTECH HOLDINGS Chart 1 Jahr
5-Tage-Chart
VIVA BIOTECH HOLDINGS 5-Tage-Chart
RealtimeGeldBriefZeit
0,0700,08013:50

Aktuelle News zur VIVA BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
26.04.VIVA BIOTECH (01873): NOTICE OF PUBLICATION OF ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023 OF THE COMPANY (THE "2023 ESG REPORT")-
26.04.VIVA BIOTECH (01873): 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT1
26.04.VIVA BIOTECH (01873): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS-
26.04.VIVA BIOTECH (01873): NOTIFICATION LETTER AND CHANGE REQUEST FORM TO REGISTERED SHAREHOLDERS-
26.04.VIVA BIOTECH (01873): FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING-
26.04.VIVA BIOTECH (01873): NOTICE OF ANNUAL GENERAL MEETING1
26.04.VIVA BIOTECH (01873): PROPOSED RE-ELECTION OF RETIRING DIRECTORS PROPOSED RE-APPOINTMENT OF AUDITOR PROPOSALS FOR GRANTING OF GENERAL MANDATES TO ISSUE ...-
26.04.VIVA BIOTECH (01873): 2023 ANNUAL REPORT-
28.03.Viva Biotech Holdings: Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future75HONG KONG, March 28, 2024 /PRNewswire/ -- Highlights of the Annual Results as of December 31, 2023: Revenue reached RMB2,155.6 million Gross profit amounted to RMB738.5 million Adjusted non-IFRS...
► Artikel lesen
28.03.VIVA BIOTECH (01873): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 AND PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION ...-
18.03.VIVA BIOTECH (01873): DATE OF BOARD MEETING1
18.01.VIVA BIOTECH (01873): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION1
18.01.VIVA BIOTECH (01873): POLL RESULTS OF THE EGM HELD ON JANUARY 18, 2024; AND APPOINTMENT OF NON-EXECUTIVE DIRECTOR-
03.01.VIVA BIOTECH (01873): COMPLETION OF FULL REDEMPTION OF US$280 MILLION 1.00 PER CENT GUARANTEED CONVERTIBLE BONDS DUE 2025 (STOCK CODE: 40514)-
27.12.23VIVA BIOTECH (01873): COMPLETION OF DISCLOSEABLE TRANSACTION IN RELATION TO DISPOSAL OF EQUITY INTEREST IN A SUBSIDIARY1
27.12.23VIVA BIOTECH (01873): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS-
27.12.23VIVA BIOTECH (01873): NOTIFICATION LETTER AND CHANGE REQUEST FORM TO REGISTERED SHAREHOLDERS-
27.12.23VIVA BIOTECH (01873): FORM OF PROXY FOR USE AT THE EGM1
27.12.23VIVA BIOTECH (01873): NOTICE OF EGM-
27.12.23VIVA BIOTECH (01873): PROPOSED ADOPTION OF THE VIVA SHANGHAI PHASE I SHARE OPTION SCHEME AND THE VIVA SHANGHAI PHASE II SHARE OPTION SCHEME; PROPOSED ...-
Seite:  Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1